SUMMARY Histological sections from 24 patients with malignant melanoma of the eyelid skin were studied and correlated with clinical follow-up for an average of 8*6 years. There was an average post-treatment follow-up of 7.4 years with a cure rate of 78% in the superficial spreading group. The average follow-up in the nodular melanoma group was 9*4 years with a cure rate of 75%. Nodular melanoma patients with the lesion in the lid margin have a worse prognosis than those with the lesion on the eyelid skin.
Malignant melanoma of the eyelids, apart from the conjunctival surface, accounts for about 1% of all eyelid tumours' and slightly less than 7% of cutaneous malignant melanoma in the head and neck region.2 Because of its rarity descriptions have been based. on the study of small groups or isolated cases, and it has been difficult to establish a comprehensive and representative picture of the histology and behaviour of malignant melanoma in this situation. In the following account we describe the prognosis and histopathology in 24 patients followed up for between three and 33 years.
Patients and methods
A total of 24 patients, for whom adequate follow-up information was available, were included in the series. Their ages ranged from 18 to 80 years, with a majority presenting in the 6th and 7th decades. Females (15) were affected slightly more commonly than males (9) . More than half of the tumours were located on the eyelid margin, and a further half of these were unpigmented. The upper lid was affected in 16 patients the lower lid in eight. The distribution was equal in the medial and lateral areas of the eyelids. Although it was not possible to comment on the clinical presentation of the tumours because of the retrospective nature of the majority in this study, 25% of the patients were seen preoperatively by one Correspondence to Professor A Garner.
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of the authors (RC). Patients who presented clinically with a flat lesion ( Fig. 1) were most likely to have a superficial spreading malignant melanoma than were patients presenting with a bulky or marginal lesion (Fig. 2 ), who were more likely to have a nodular melanoma.
In our series 21 patients had surgery, two had irradiation, and one both treatments.
The type of surgery varied with the size of the lesion. The margins of the excised specimens were histologically clear in 22 patients. In two patients in whom clearance was incomplete a second surgical procedure was performed with complete removal of the residual tumour. No figures are available on the number of patients who were subjected to a diagnostic as opposed to an excisional biopsy.
Histological sections were examined from each of the 24 patients. The sections were drawn from the files of the Institute of Ophthalmology, London (21 cases), the Dutch Cancer Institute at the Antoni van Leeuwenhoek Ziekenhuis (two cases), and the Royal Marsden Hospital, London (one case). Representative haematoxylin and eosin stained sections, including bleached preparations, were reviewed by two of the authors (AG and AL) using diagnostic criteria as defined by Levene.3 Three categories of invasive melanoma were recognised for the purpose of classi- (Haematoxylin and eosin, x 400). 9.4 yr, with all of the surviving cases being followed up for 5 yr or more. Of the 12 patients four died, with evidence of metastasis in three of them. The remaining death occurred a few hours after surgery for removal of a local recurrence. One of the patients who died underwent a block dissection of the neck for cervical lymph node metastasis one year after the initial excision, death from multiple metastasis occurring some 10 yr later. In one surviving patient (No. 21) the initial removal was incomplete, and a second surgical excision was required six months afterwards: she is alive and well four years after the first operation. Unclassified malignant melanoma. The three patients in this group were followed up for 12, seven, and eight years respectively. The single fatality The prognosis of cutaneous malignant melanoma relates also to the depths of invasion.8 1112 A similar consideration applies to malignant melanoma of the conjunctiva, where a thickness of under 1-5 mm usually implies a favourable outcome after treata ment. '' The maximum tumour thicknesses in the four patients with a fatal outcome in whom it was possible to take measurements were 0-5, 3 3, 1*7, 2*5 mm respectively. There were, however, eight patients in whom the tumour measured 1-5 mm or more who were alive and well at the time of review. To some extent the curvature of the eyelid at the margin where it meets the conjunctiva makes it difficult to determine the point from which measurements of thickness should be made, but even with this allowance the impression gained is that, size for size, malignant melanoma of the eyelid skin has a slightly better prognosis than its counterpart elsewhere. Whether a grading based on the tissue level reached by the invading tumour is applicable to the eyelid is debatable, since the total dermis (both papillary and reticular) is exceptionally thin in this region, and a stage V melanoma on the Clark et al. "I scale would often be a much smaller lesion than such staging would represent in other parts of the integument. For this reason we have chosen to confine ourselves to simple thickness measurements.
The generally good response to surgical excision suggests that this is the preferred treatment. Of the 21 patients with surgery three had a tumour related death, but both the patients treated with irradiation died with metastases. In none of the patients treated with primary surgery was there evidence of local recurrence. Only two patients developed cervical lymphnode metastases, one of them undergoing a cervical block dissection, but the other had cerebral metastasis diagnosed at the same time.
Finally we consider that the possible late presentation of metastases means that this and any similar study must follow up patients for at least 15 years. 
